BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25597409)

  • 1. Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma.
    Lecointre C; Desrues L; Joubert JE; Perzo N; Guichet PO; Le Joncour V; Brulé C; Chabbert M; Leduc R; Prézeau L; Laquerrière A; Proust F; Gandolfo P; Morin F; Castel H
    Oncogene; 2015 Sep; 34(39):5080-94. PubMed ID: 25597409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma.
    Le Joncour V; Guichet PO; Dembélé KP; Mutel A; Campisi D; Perzo N; Desrues L; Modzelewski R; Couraud PO; Honnorat J; Ferracci FX; Marguet F; Laquerrière A; Vera P; Bohn P; Langlois O; Morin F; Gandolfo P; Castel H
    Front Cell Dev Biol; 2021; 9():652544. PubMed ID: 33937253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urotensin II induces migration of endothelial progenitor cells via activation of the RhoA/Rho kinase pathway.
    Xu S; Jiang H; Wu B; Yang J; Chen S
    Tohoku J Exp Med; 2009 Dec; 219(4):283-8. PubMed ID: 19966526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UII/UT system mediates upregulation of proinflammatory cytokines through p38 MAPK and NF-κB pathways in LPS-stimulated Kupffer cells.
    Liu LM; Liang DY; Ye CG; Tu WJ; Zhu T
    PLoS One; 2015; 10(3):e0121383. PubMed ID: 25803040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.
    Dubessy C; Cartier D; Lectez B; Bucharles C; Chartrel N; Montero-Hadjadje M; Bizet P; Chatenet D; Tostivint H; Scalbert E; Leprince J; Vaudry H; Jégou S; Lihrmann I
    J Neurochem; 2008 Oct; 107(2):361-74. PubMed ID: 18710417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GABA A receptor activation on UT-coupled signaling pathways in rat cortical astrocytes.
    Desrues L; Lefebvre T; Diallo M; Gandolfo P; Leprince J; Chatenet D; Vaudry H; Tonon MC; Castel H
    Peptides; 2008 May; 29(5):727-34. PubMed ID: 18355946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.
    Castel H; Desrues L; Joubert JE; Tonon MC; Prézeau L; Chabbert M; Morin F; Gandolfo P
    Front Endocrinol (Lausanne); 2017; 8():76. PubMed ID: 28487672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes.
    Segain JP; Rolli-Derkinderen M; Gervois N; Raingeard de la Blétière D; Loirand G; Pacaud P
    J Immunol; 2007 Jul; 179(2):901-9. PubMed ID: 17617581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues.
    Morimoto R; Satoh F; Murakami O; Totsune K; Arai Y; Suzuki T; Sasano H; Ito S; Takahashi K
    Peptides; 2008 May; 29(5):873-80. PubMed ID: 17686550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.
    Kristof AS; You Z; Han YS; Giaid A
    Peptides; 2010 Aug; 31(8):1511-6. PubMed ID: 20433884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization and expression of urotensin II and its receptor in the flounder (Platichthys flesus): a hormone system supporting body fluid homeostasis in euryhaline fish.
    Lu W; Greenwood M; Dow L; Yuill J; Worthington J; Brierley MJ; McCrohan CR; Riccardi D; Balment RJ
    Endocrinology; 2006 Aug; 147(8):3692-708. PubMed ID: 16675528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity.
    Desrues L; Lefebvre T; Lecointre C; Schouft MT; Leprince J; Compère V; Morin F; Proust F; Gandolfo P; Tonon MC; Castel H
    PLoS One; 2012; 7(5):e36319. PubMed ID: 22563490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro.
    Spinazzi R; Albertin G; Nico B; Guidolin D; Di Liddo R; Rossi GP; Ribatti D; Nussdorfer GG
    Int J Mol Med; 2006 Dec; 18(6):1107-12. PubMed ID: 17089015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of urotensin II on migration and invasion are mediated by NADPH oxidase-derived reactive oxygen species through the c-Jun N-terminal kinase pathway in human hepatoma cells.
    Li YY; Shi ZM; Yu XT; Feng P; Wang XJ
    Peptides; 2017 Feb; 88():106-114. PubMed ID: 27988353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker.
    Rakowski E; Hassan GS; Dhanak D; Ohlstein EH; Douglas SA; Giaid A
    J Mol Cell Cardiol; 2005 Nov; 39(5):785-91. PubMed ID: 16171813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin II and its receptor in the killifish gill: regulators of NaCl extrusion.
    Evans DH; Hyndman KA; Cornwell E; Buchanan P
    J Exp Biol; 2011 Dec; 214(Pt 23):3985-91. PubMed ID: 22071190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urantide alleviates the symptoms of atherosclerotic rats in vivo and in vitro models through the JAK2/STAT3 signaling pathway.
    Wang T; Xie L; Bi H; Li Y; Li Y; Zhao J
    Eur J Pharmacol; 2021 Jul; 902():174037. PubMed ID: 33891969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function.
    Vaudry H; Leprince J; Chatenet D; Fournier A; Lambert DG; Le Mével JC; Ohlstein EH; Schwertani A; Tostivint H; Vaudry D
    Pharmacol Rev; 2015; 67(1):214-58. PubMed ID: 25535277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging roles of urotensin-II in cardiovascular disease.
    Russell FD
    Pharmacol Ther; 2004 Sep; 103(3):223-43. PubMed ID: 15464591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
    Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
    Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.